Venture Capital Access Online | The eMarketplace for the Venture Capital Industry

 

Home

Marketplace
Database
News
Store
Resources
Contact Us

 

 

News


VENTURE CAPITAL DIRECTORY | PRIVATE EQUITY DIRECTORY

List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro Database is the most reliable, up-to-date and affordable venture capital directory

2022 EDITION NOW AVAILABLE!
Buy Now for $119.95 with a FREE mid-year update in July 2022
Learn More or Buy Now

VCPro Database 2022 25th Edition -- a downloadable and searchable venture capital database with 6,600+ venture capital and private equity firms worldwide. The most reliable, up-to-date and affordable venture capital directory of its kind. VCPro Database is available in both Windows and macOS versions. It has been published since 1998. (Updated JANUARY 2022)

Learn More » or Buy Now »




Third Rock Ventures Raises $1.1 Billion Fund VI

BOSTON, June 15, 2022-- Third Rock Ventures today announced the closing of Third Rock Ventures Fund VI, raising $1.1 billion. Fund VI will continue Third Rock’s core strategy to discover, launch and build new groundbreaking companies focused on improving the lives of patients. Third Rock employs a hands-on approach to partnering with founders to build companies and provides early and rigorous integration of science, medicine, business and strategy to build successful companies.

“An important differentiator for Third Rock is the strength and maturity of our ideation ecosystem,” said Reid Huber, Ph.D., partner at Third Rock. “Our discovery pipeline is as robust as it has ever been, and with our established and proven model for integrating deep scientific and medical expertise with operational and business acumen, we are uniquely positioned to advance these innovations to patients.”

To date, Third Rock has raised $3.8 billion and its funds have invested in 60 companies. Importantly, companies across the portfolio have brought 18 products to the market across multiple therapeutic modalities and a broad range of disease indications including cancer, cardiovascular disease, depression, sickle cell disease, and rare genetic diseases among others. Fund VI is able to provide both initial Series A as well as follow-on capital to support companies throughout their lifecycle. Furthermore, Third Rock intends to allocate capital from Fund VI to invest in groundbreaking new companies from in the broader biotech ecosystem that are strongly aligned with Third Rock’s mission and strategy.

“We believe that people are our greatest asset, and we invest significant effort and resources to ensure we hire the best people at Third Rock and across the portfolio,” said Abbie Celniker, Ph.D., partner at Third Rock. “The internal team at Third Rock consists of ideators, experienced company builders, technology developers, and domain experts critical to the success of developing companies.”

The partners of Fund VI are Abbie Celniker, Ph.D., Neil Exter, Kevin Gillis, Reid Huber, Ph.D., David Kaufman, M.D., Ph.D., Cary Pfeffer, M.D., Robert Tepper, M.D., Ph.D., and Jeffrey Tong, Ph.D. Third Rock is also announcing today the promotion of Dodzie Sogah, Ph.D., to venture partner. Dr. Sogah came to the firm in 2021 as an entrepreneur-in-residence, and now joins an exceptional team of business and scientific leaders in the venture partner role.

“Over the course of our 15-year history, our focus on creating companies aimed at improving the lives of patients has not wavered,” said Kevin Gillis, partner and chief operating officer at Third Rock. “We have built a leading investor base that is supportive of our differentiated model that is hands on, team oriented, value creation driven, and built for the long term. We appreciate the strong support from existing limited partners and welcome our new investors.”

About Third Rock Ventures

Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients. By starting with big ideas and fostering collaboration among people with expertise in science, medicine, business and strategy, we aim to discover, launch and build innovative companies that can transform the lives of patients. Our mission is to be the preferred partner for entrepreneurs, investors, employees and industry to build great companies that discover and develop products that make a difference for the patients we serve. For more information, please visit www.thirdrockventures.com.

Contact:
Cynthia Clayton
Third Rock Ventures
cclayton@thirdrockventures.com


News Index

Venture Capital Database 

 

 NEWS

Latest VC News
VC News Archive
News Search

List Your Firm

Entrepreneurs
Investors
Advisors

Venture Capital Database

VCPro Database
Download Trial
Buy Now

Business Plan Tools

Free Business Plan Template

 

Copyright © 1998-2022 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer